Coffee Consumption and Colorectal Cancer Survival: A Dose–Response Meta-analysis by Coffee Type and Disease Stage
This meta-analysis demonstrates stage- and type-specific survival benefits in colorectal cancer, which may inform more individualized dietary recommendations. It also underscores the need for validation in diverse cohorts and mechanistic studies.
Authors
- Joon‐Yong Chung (ORCID: https://orcid.org/0000-0001-5041-5982)
- Yong-Hwi Kang (ORCID: https://orcid.org/0009-0009-7640-5286)
- Yo‐Chan Ahn (ORCID: https://orcid.org/0000-0002-1092-5280)
- Yujin Choi (ORCID: https://orcid.org/0000-0003-4371-6239)
- Jun-Yeol Kim (ORCID: https://orcid.org/0000-0002-8570-6170)
- Dong‐Soo Lee (ORCID: https://orcid.org/0000-0001-9198-0785)
- Chang‐Gue Son (ORCID: https://orcid.org/0000-0003-4876-0167)
- Chong-Kwan Cho (ORCID: https://orcid.org/0009-0002-7124-6027)
Institutions
- Daejeon University (KR)
- The Catholic University of Korea Daejeon St. Mary's Hospital (KR)
- National Cancer Institute (US)
- Daejeon Oriental Hospital (KR)
- Daejeon Health Institute of Technology (KR)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1158/1055-9965.epi-25-1485
- Primary Topic
- Coffee research and impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00